Hepion Pharmaceuticals, Inc.
HEPA
$0.3204
$0.02297.70%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.79M | 1.70M | 1.37M | 2.64M | 1.78M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.20M | 4.46M | 8.50M | 5.18M | 7.22M |
| Operating Income | -1.20M | -4.46M | -8.50M | -5.18M | -7.22M |
| Income Before Tax | -1.55M | -4.87M | -3.93M | -5.82M | -11.47M |
| Income Tax Expenses | 0.00 | -- | -- | -2.97M | -409.00K |
| Earnings from Continuing Operations | -1.55M | -4.87M | -3.93M | -2.85M | -11.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.55M | -4.87M | -3.93M | -2.85M | -11.06M |
| EBIT | -1.20M | -4.46M | -8.50M | -5.18M | -7.22M |
| EBITDA | -1.20M | -4.46M | -8.50M | -5.15M | -7.21M |
| EPS Basic | -11.11 | -36.21 | -33.84 | -28.13 | -125.49 |
| Normalized Basic EPS | -11.75 | -22.94 | -45.56 | -47.77 | -51.21 |
| EPS Diluted | -11.11 | -36.21 | -33.84 | -28.13 | -125.49 |
| Normalized Diluted EPS | -11.75 | -22.94 | -45.56 | -47.77 | -51.21 |
| Average Basic Shares Outstanding | 139.30K | 134.40K | 116.00K | 101.50K | 88.10K |
| Average Diluted Shares Outstanding | 139.30K | 134.40K | 116.00K | 101.50K | 88.10K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |